CN Patent

CN119909081B — 一种抑制卵巢癌的组合物、纳米颗粒、制备方法和应用

Assigned to HUNAN XINHUI PHARMACEUTICAL CO Ltd · Expires 2025-12-05 · 0y expired

What this patent protects

本发明属于纳米医学技术领域，具体涉及一种抑制卵巢癌的组合物、纳米颗粒、制备方法和应用，包括蟾毒它灵和尼拉帕利，所述蟾毒它灵和尼拉帕利的摩尔比为6.25‑12.5:5000‑10000，本发明能够提高卵巢癌的抑制效果。

USPTO Abstract

本发明属于纳米医学技术领域，具体涉及一种抑制卵巢癌的组合物、纳米颗粒、制备方法和应用，包括蟾毒它灵和尼拉帕利，所述蟾毒它灵和尼拉帕利的摩尔比为6.25‑12.5:5000‑10000，本发明能够提高卵巢癌的抑制效果。

Drugs covered by this patent

Patent Metadata

Patent number: CN119909081B
Jurisdiction: CN
Classification: —
Expires: 2025-12-05
Drug substance claim: No
Drug product claim: No
Assignee: HUNAN XINHUI PHARMACEUTICAL CO Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.